(Q48123921)

8 February 2018

title

Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor. (English)

1 reference

8 February 2018

author name string

J W Polli

1

1 reference

8 February 2018

J L Jarrett

2

1 reference

8 February 2018

S D Studenberg

3

1 reference

8 February 2018

J E Humphreys

4

1 reference

8 February 2018

S W Dennis

5

1 reference

8 February 2018

K R Brouwer

6

1 reference

8 February 2018

J L Woolley

7

1 reference

8 February 2018

publication date

1 August 1999

1 reference

8 February 2018

published in

Pharmaceutical Research

1 reference

8 February 2018

volume

16

1 reference

8 February 2018

page(s)

1206-1212

1 reference

8 February 2018

issue

8

1 reference

8 February 2018

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

cites work

1 reference

12 December 2020

Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).

1 reference

12 December 2020

Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers

1 reference

12 December 2020

In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

1 reference

12 December 2020

In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents.

1 reference

12 December 2020

Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.

1 reference

12 December 2020

Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat

1 reference

12 December 2020

Weak binding of VX-478 to human plasma proteins and implications for anti-human immunodeficiency virus therapy

1 reference

12 December 2020

Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus

1 reference

12 December 2020

Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues

1 reference

12 December 2020

1 reference

12 December 2020

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

1 reference

12 December 2020

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

12 December 2020

Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists

1 reference

12 December 2020

HIV protease inhibitors

1 reference

12 December 2020

The neuropathogenesis of the AIDS dementia complex.

1 reference

12 December 2020

Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers

1 reference

12 December 2020

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

1 reference

12 December 2020

Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP

1 reference

12 December 2020

Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor

1 reference

12 December 2020

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

12 December 2020

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1 reference

12 December 2020

P-glycoprotein and related transporters.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018941328702

1 reference

8 February 2018

PubMed ID

10468021

1 reference

8 February 2018